Incidence of Hypoxia During Intravitreal Anti-VEGF (Vascular Endothelial Growth Factor) Injections for Retinopathy of Prematurity (ROP) Under Topical Anesthesia
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Ranibizumab
Related studies linked through entity extraction aliases.
Outcomes of Intravitreal Ranibizumab Injection for Diabetic Vitreous Hemorrhage
- Status
- COMPLETED
- Phase
- PHASE4
Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting
- Status
- RECRUITING
- Phase
- NA
A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
- Status
- COMPLETED
- Phase
- PHASE3
This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD
- Status
- UNKNOWN
- Phase
- PHASE3
Ranibizumab Versus Aflibercept for CRVO in Young Patients.
- Status
- UNKNOWN
- Phase
- PHASE4
Anti-VEGF in Real-world
- Status
- UNKNOWN
- Phase
- N/A
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
- Status
- WITHDRAWN
- Phase
- PHASE3
601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD
- Status
- COMPLETED
- Phase
- PHASE3
A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections
- Status
- COMPLETED
- Phase
- N/A
A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3